The connection between COMT (catechol-O-methyltransferase) and gut health is a complex but not yet well-established area. COMT is a key enzyme for breaking down catecholamines (dopamine, adrenaline) and inactivating estrogens. Genetic variants (e.g., rs4680, Val158Met) affect enzyme activity: carriers of the Met variant have lower activity, potentially leading to higher dopamine and estrogen levels. Through the gut-brain axis, this could indirectly influence gut motility, stress response, and microbiome composition. However, direct clinical studies linking COMT polymorphisms to specific gut parameters like inflammation, permeability, or dysbiosis are lacking. The existing evidence is mostly mechanistic or from animal studies. A home gut test from MyBody-X does not measure COMT markers; the company's DNA tests also appear not to include COMT (based on the provided context). If you know your COMT status, it should not be used as the sole basis for gut interventions. Instead, proven strategies like a high-fiber diet, stress management, and targeted micronutrient support (e.g., methylfolate, magnesium) are advisable – always in consultation with a physician.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-531b6e84ed351f429bd0cb8f